Cargando…
A review of bronchiolitis obliterans syndrome and therapeutic strategies
Lung transplantation is an important treatment option for patients with advanced lung disease. Survival rates for lung transplant recipients have improved; however, the major obstacle limiting better survival is bronchiolitis obliterans syndrome (BOS). In the last decade, survival after lung retrans...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162889/ https://www.ncbi.nlm.nih.gov/pubmed/21767391 http://dx.doi.org/10.1186/1749-8090-6-92 |
_version_ | 1782210893034029056 |
---|---|
author | Hayes, Don |
author_facet | Hayes, Don |
author_sort | Hayes, Don |
collection | PubMed |
description | Lung transplantation is an important treatment option for patients with advanced lung disease. Survival rates for lung transplant recipients have improved; however, the major obstacle limiting better survival is bronchiolitis obliterans syndrome (BOS). In the last decade, survival after lung retransplantation has improved for transplant recipients with BOS. This manuscript reviews BOS along with the current therapeutic strategies, including recent outcomes for lung retransplantation. |
format | Online Article Text |
id | pubmed-3162889 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31628892011-08-28 A review of bronchiolitis obliterans syndrome and therapeutic strategies Hayes, Don J Cardiothorac Surg Review Lung transplantation is an important treatment option for patients with advanced lung disease. Survival rates for lung transplant recipients have improved; however, the major obstacle limiting better survival is bronchiolitis obliterans syndrome (BOS). In the last decade, survival after lung retransplantation has improved for transplant recipients with BOS. This manuscript reviews BOS along with the current therapeutic strategies, including recent outcomes for lung retransplantation. BioMed Central 2011-07-18 /pmc/articles/PMC3162889/ /pubmed/21767391 http://dx.doi.org/10.1186/1749-8090-6-92 Text en Copyright ©2011 Hayes; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Hayes, Don A review of bronchiolitis obliterans syndrome and therapeutic strategies |
title | A review of bronchiolitis obliterans syndrome and therapeutic strategies |
title_full | A review of bronchiolitis obliterans syndrome and therapeutic strategies |
title_fullStr | A review of bronchiolitis obliterans syndrome and therapeutic strategies |
title_full_unstemmed | A review of bronchiolitis obliterans syndrome and therapeutic strategies |
title_short | A review of bronchiolitis obliterans syndrome and therapeutic strategies |
title_sort | review of bronchiolitis obliterans syndrome and therapeutic strategies |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162889/ https://www.ncbi.nlm.nih.gov/pubmed/21767391 http://dx.doi.org/10.1186/1749-8090-6-92 |
work_keys_str_mv | AT hayesdon areviewofbronchiolitisobliteranssyndromeandtherapeuticstrategies AT hayesdon reviewofbronchiolitisobliteranssyndromeandtherapeuticstrategies |